Gritstone bio Statistics
Total Valuation
Gritstone bio has a market cap or net worth of 2.73 million. The enterprise value is 49.51 million.
| Market Cap | 2.73M |
| Enterprise Value | 49.51M |
Important Dates
The last earnings date was Thursday, November 14, 2024.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Gritstone bio has 118.11 million shares outstanding. The number of shares has increased by 17.64% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 118.11M |
| Shares Change (YoY) | +17.64% |
| Shares Change (QoQ) | +21.04% |
| Owned by Insiders (%) | 2.26% |
| Owned by Institutions (%) | 21.54% |
| Float | 115.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.20 |
| PB Ratio | 0.12 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.37 |
| EV / Sales | 3.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.44 |
Financial Position
The company has a current ratio of 2.54, with a Debt / Equity ratio of 4.62.
| Current Ratio | 2.54 |
| Quick Ratio | 2.34 |
| Debt / Equity | 4.62 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.91 |
| Interest Coverage | -28.38 |
Financial Efficiency
Return on equity (ROE) is -201.94% and return on invested capital (ROIC) is -51.75%.
| Return on Equity (ROE) | -201.94% |
| Return on Assets (ROA) | -46.71% |
| Return on Capital (ROIC) | -51.75% |
| Revenue Per Employee | 63,247 |
| Profits Per Employee | -575,900 |
| Employee Count | 231 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.31% in the last 52 weeks. The beta is 0.50, so Gritstone bio's price volatility has been lower than the market average.
| Beta (5Y) | 0.50 |
| 52-Week Price Change | -98.31% |
| 50-Day Moving Average | 0.23 |
| 200-Day Moving Average | 0.92 |
| Relative Strength Index (RSI) | 25.09 |
| Average Volume (20 Days) | 6,254,048 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.18 |
Income Statement
In the last 12 months, Gritstone bio had revenue of 14.61 million and -133.03 million in losses. Loss per share was -1.08.
| Revenue | 14.61M |
| Gross Profit | -104.94M |
| Operating Income | -136.47M |
| Pretax Income | -133.03M |
| Net Income | -133.03M |
| EBITDA | -129.23M |
| EBIT | -136.47M |
| Loss Per Share | -1.08 |
Balance Sheet
The company has 55.71 million in cash and 102.49 million in debt, giving a net cash position of -46.78 million or -0.40 per share.
| Cash & Cash Equivalents | 55.71M |
| Total Debt | 102.49M |
| Net Cash | -46.78M |
| Net Cash Per Share | -0.40 |
| Equity (Book Value) | 22.19M |
| Book Value Per Share | 0.19 |
| Working Capital | 36.81M |
Cash Flow
In the last 12 months, operating cash flow was -110.97 million and capital expenditures -1.46 million, giving a free cash flow of -112.43 million.
| Operating Cash Flow | -110.97M |
| Capital Expenditures | -1.46M |
| Free Cash Flow | -112.43M |
| FCF Per Share | -0.95 |
Margins
| Gross Margin | n/a |
| Operating Margin | -934.05% |
| Pretax Margin | -910.56% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -769.56% |
Dividends & Yields
Gritstone bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.64% |
| Shareholder Yield | -17.64% |
| Earnings Yield | -4,663.97% |
| FCF Yield | -4,120.92% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Gritstone bio has an Altman Z-Score of -9.03. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.03 |
| Piotroski F-Score | n/a |